更正：通过针对严重慢性非传染性疾病的 PEN-Plus 战略，为世界上最贫穷的十亿人提供高级心脏护理的权力下放和整合。

IF 3 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Global Heart Pub Date : 2024-06-26 eCollection Date: 2024-01-01 DOI:10.5334/gh.1338

Sheila L Klassen, Emmy Okello, Jose M E Ferrer, Faraz Alizadeh, Prebo Barango, Pilly Chillo, Yamikani Chimalizeni, Wubaye Walelgne Dagnaw, Jean-Luc Eiselé, Lauren Eberly, Anu Gomanju, Neil Gupta, Bhagawan Koirala, Jacques Kpodonu, Gene F Kwan, Bright G D Mailosi, Lilian Mbau, Reuben Mutagaywa, Judith Namuyonga, Colin Pfaff, Daniel Piñero, Fausto Pinto, Emmanuel Rusingiza, Usman Abiola Sanni, Amy Sanyahumbi, Urmila Shakya, Sanjib Kumar Sharma, Kunjang Sherpa, Isaac Sinabulya, Emily B Wroe, Gene Bukhman, Ana Mocumbi

引用次数: 0

摘要

[此处更正了文章 DOI：10.5334/gh.1313.]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Correction: Decentralization and Integration of Advanced Cardiac Care for the World's Poorest Billion Through the PEN-Plus Strategy for Severe Chronic Non-Communicable Disease.

[This corrects the article DOI: 10.5334/gh.1313.].

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Global Heart Medicine-Cardiology and Cardiovascular Medicine

CiteScore

5.70

自引率

5.40%

发文量

审稿时长

5 weeks

期刊介绍： Global Heart offers a forum for dialogue and education on research, developments, trends, solutions and public health programs related to the prevention and control of cardiovascular diseases (CVDs) worldwide, with a special focus on low- and middle-income countries (LMICs). Manuscripts should address not only the extent or epidemiology of the problem, but also describe interventions to effectively control and prevent CVDs and the underlying factors. The emphasis should be on approaches applicable in settings with limited resources. Economic evaluations of successful interventions are particularly welcome. We will also consider negative findings if important. While reports of hospital or clinic-based treatments are not excluded, particularly if they have broad implications for cost-effective disease control or prevention, we give priority to papers addressing community-based activities. We encourage submissions on cardiovascular surveillance and health policies, professional education, ethical issues and technological innovations related to prevention. Global Heart is particularly interested in publishing data from updated national or regional demographic health surveys, World Health Organization or Global Burden of Disease data, large clinical disease databases or registries. Systematic reviews or meta-analyses on globally relevant topics are welcome. We will also consider clinical research that has special relevance to LMICs, e.g. using validated instruments to assess health-related quality-of-life in patients from LMICs, innovative diagnostic-therapeutic applications, real-world effectiveness clinical trials, research methods (innovative methodologic papers, with emphasis on low-cost research methods or novel application of methods in low resource settings), and papers pertaining to cardiovascular health promotion and policy (quantitative evaluation of health programs.